SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$5.36
+0.04 (+0.75%)
Open$5.32
Previous Close$5.32
Day High$5.46
Day Low$5.22
52W High$18.00
52W Low$4.91
Volume—
Avg Volume2.47M
Market Cap611.71M
P/E Ratio—
EPS$-2.00
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,129.7% upside
Current
$5.36
$5.36
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 97.58M | 357.40M | 350.63M |
| Net Income | -198,337,221 | 35.24M | 44.72M |
| Profit Margin | -203.3% | 9.9% | 12.8% |
| EBITDA | -206,850,920 | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | +299.7% | +16.3% | -1.3% |
| Debt/Equity | 0.84 | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |